SCHEMBL19081701

SCHEMBL19081701

c1ccc2cc3c(cc2c1)oc1c3ccc2c3ccc(-c4c5ccccc5c(-c5ccc6c(c5)oc5ccccc56)c5ccccc45)cc3oc21

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.42
MAPT P10636 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
ALOX5 P09917 2/20 0.40
HCRTR1 O43613 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PRKDC P78527 1/20 0.37
DYRK1A Q13627 1/20 0.37
MAOA P21397 3/20 0.36
DUSP3 P51452 1/20 0.36
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36
PGR P06401 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081698 0.96 MAPT (0.41) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL20127556 0.94 AHR (0.47) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17931988 0.91 MAPT (0.45) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17931987 0.91 MAPT (0.45) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17944554 0.91 AHR (0.50) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL19076578 0.91 HCRTR1 (0.41) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL20127553 0.91 ALOX5 (0.48) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL19076499 0.90 CYP1A1 (0.40) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17945000 0.90 CYP1A1 (0.43) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL20127560 0.90 ALOX5 (0.50) AHRMAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 AHR 2453/4885MAPT 1294/4885MEN1 277/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 AHR 2453/4885MAPT 1294/4885MEN1 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.